Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells
Authors:
- Ying-Chun DouYDYing-Chun Dou
- Ying LiuYLYing Liu
- Chang-Wen ShiCSChang-Wen Shi
- Li-Li CaoLCLi-Li Cao
- Xiu-Qing ZhangXZXiu-Qing Zhang
- Jie ZhuJZJie Zhu
- Rui-Sheng DuanRDRui-Sheng Duan
- 1 January 2011
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 271 (2) , 455-461
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Atorvastatin attenuates inflammatory infiltration and vascular remodeling in lung of hypercholesterolemia rabbitsExperimental Lung Research, 2010
- AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritisJournal of Neuroimmunology, 2009
- How regulatory T cells workNature Reviews Immunology, 2008
- The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cellsAtherosclerosis, 2008
- TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1Nature Medicine, 2007
- Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through AtorvastatinJournal of Experimental Medicine, 2003
- Lovastatin inhibits brain endothelial cell Rho‐mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitisThe FASEB Journal, 2003
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Cytokine Dichotomy in Peripheral Nervous System Influences the Outcome of Experimental Allergic Neuritis: Dynamics of mRNA Expression for IL-1β, IL-6, IL-10, IL-12, TNF-α, TNF-β, and CytolysinClinical Immunology and Immunopathology, 1997